bbm-h901
Gene therapyexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2019 (NCT04135300)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Coagulation factor IXSupplementation
F9 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05709288 | Phase 1 | Mar 23, 2023 | China Academy of Chinese Medical Sciences |
| NCT05203679 | Phase 1/Phase 2 (Phase 2) | Dec 30, 2021 | Chinese Academy of Medical Sciences, Government of China |
| NCT04135300 | N/A | Oct 31, 2019 | Chinese Academy of Medical Sciences, East China University of Science and Technology |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 2 | 1 | 2 | 2019 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2023 |
| East China University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Government of China | Government | 1 | 1 | 1 | 2021 |
4 organizations
Page 1 / 1